2.The method of claim 1 wherein the compound is a neuroprotectant and the treatment improves preservation of vision after onset of the acute demyelinating optic neuritis. 3.The method of claim 2 wherein neuroprotection is achieved by partial blocking of voltage-gated sodium channels in axonal and...